Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2006 Dec;3(12):e538; author reply e550.
doi: 10.1371/journal.pmed.0030538.

HIV-1 viral load assays for resource-limited settings: clades matter

Comment

HIV-1 viral load assays for resource-limited settings: clades matter

Wolfgang Preiser et al. PLoS Med. 2006 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Comment on

  • HIV-1 viral load assays for resource-limited settings.
    Fiscus SA, Cheng B, Crowe SM, Demeter L, Jennings C, Miller V, Respess R, Stevens W; Forum for Collaborative HIV Research Alternative Viral Load Assay Working Group. Fiscus SA, et al. PLoS Med. 2006 Oct;3(10):e417. doi: 10.1371/journal.pmed.0030417. PLoS Med. 2006. PMID: 17032062 Free PMC article. Review.

References

    1. Fiscus SA, Cheng B, Crowe SM, Demeter L, Jennings C, et al. HIV-1 viral load assays for resource-limited settings. PLoS Med. 2006;3:e417. doi: 10.1371/journal.pmed.0030417. - DOI - PMC - PubMed
    1. Gordon M, De Oliveira T, Bishop K, Coovadia HM, Madurai L, et al. Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from Kwazulu-Natal, South Africa: Implications for vaccine and antiretroviral control strategies. J Virol. 2003;77:2587–2599. - PMC - PubMed
    1. Drosten C, Panning M, Drexler JF, Hansel F, Pedroso C, et al. Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5' long terminal repeat domain. Clin Chem. 2006;52:1258–1266. - PMC - PubMed
    1. Wensing AM, van de Vijver DA, Angarano G, Asjo B, Balotta C, et al. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management. J Infect Dis. 2005;192:958–966. - PubMed
    1. Sutthent R, Arworn D, Kaoriangudom S, Chokphaibulkit K, Chaisilwatana P, et al. HIV-1 drug resistance in Thailand: Before and after national access to antiretroviral program. J Clin Virol. 2005;34:272–276. - PubMed